The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism - PubMed (original) (raw)
Review
doi: 10.1038/nrg1879.
Affiliations
- PMID: 16847462
- DOI: 10.1038/nrg1879
Review
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A Engelman et al. Nat Rev Genet. 2006 Aug.
Abstract
Phosphatidylinositol 3-kinases (PI3Ks) evolved from a single enzyme that regulates vesicle trafficking in unicellular eukaryotes into a family of enzymes that regulate cellular metabolism and growth in multicellular organisms. In this review, we examine how the PI3K pathway has evolved to control these fundamental processes, and how this pathway is in turn regulated by intricate feedback and crosstalk mechanisms. In light of the recent advances in our understanding of the function of PI3Ks in the pathogenesis of diabetes and cancer, we discuss the exciting therapeutic opportunities for targeting this pathway to treat these diseases.
Similar articles
- Gene-targeting reveals physiological roles and complex regulation of the phosphoinositide 3-kinases.
Foukas LC, Okkenhaug K. Foukas LC, et al. Arch Biochem Biophys. 2003 Jun 1;414(1):13-8. doi: 10.1016/s0003-9861(03)00177-2. Arch Biochem Biophys. 2003. PMID: 12745249 Review. - Classes of phosphoinositide 3-kinases at a glance.
Jean S, Kiger AA. Jean S, et al. J Cell Sci. 2014 Mar 1;127(Pt 5):923-8. doi: 10.1242/jcs.093773. J Cell Sci. 2014. PMID: 24587488 Free PMC article. Review. - Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer.
Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, Waterfield MD. Katso R, et al. Annu Rev Cell Dev Biol. 2001;17:615-75. doi: 10.1146/annurev.cellbio.17.1.615. Annu Rev Cell Dev Biol. 2001. PMID: 11687500 Review. - Signaling by the phosphoinositide 3-kinase family in immune cells.
Okkenhaug K. Okkenhaug K. Annu Rev Immunol. 2013;31:675-704. doi: 10.1146/annurev-immunol-032712-095946. Epub 2013 Jan 16. Annu Rev Immunol. 2013. PMID: 23330955 Free PMC article. Review. - Advances in subunits of PI3K class I in cancer.
Cui W, Cai Y, Zhou X. Cui W, et al. Pathology. 2014 Apr;46(3):169-76. doi: 10.1097/PAT.0000000000000066. Pathology. 2014. PMID: 24614719 Review.
Cited by
- Carotenoids as modulators of the PI3K/Akt/mTOR pathway: innovative strategies in cancer therapy.
Utpal BK, Dehbia Z, Zidan BMRM, Sweilam SH, Singh LP, Arunkumar MS, Sona M, Panigrahy UP, Keerthana R, Mandadi SR, Rab SO, Alshehri MA, Koula D, Suliman M, Nafady MH, Emran TB. Utpal BK, et al. Med Oncol. 2024 Nov 16;42(1):4. doi: 10.1007/s12032-024-02551-x. Med Oncol. 2024. PMID: 39549201 Review. - Mechanisms of endocrine resistance in hormone receptor-positive breast cancer.
Gao Y, Yu Y, Zhang M, Yu W, Kang L. Gao Y, et al. Front Oncol. 2024 Oct 31;14:1448687. doi: 10.3389/fonc.2024.1448687. eCollection 2024. Front Oncol. 2024. PMID: 39544302 Free PMC article. Review. - Identification of novel inhibitors targeting PI3Kα via ensemble-based virtual screening method, biological evaluation and molecular dynamics simulation.
Zhang H, Qi HZ, Li YJ, Shi XY, Hu ML, Chen XL, Li Y. Zhang H, et al. J Comput Aided Mol Des. 2024 Nov 11;38(1):37. doi: 10.1007/s10822-024-00580-2. J Comput Aided Mol Des. 2024. PMID: 39528618 - The Importance of Phosphoinositide 3-Kinase in Neuroinflammation.
Wright B, King S, Suphioglu C. Wright B, et al. Int J Mol Sci. 2024 Oct 30;25(21):11638. doi: 10.3390/ijms252111638. Int J Mol Sci. 2024. PMID: 39519189 Free PMC article. Review. - Revisiting the role of MicroRNAs in the pathogenesis of idiopathic pulmonary fibrosis.
Zhou Z, Xie Y, Wei Q, Zhang X, Xu Z. Zhou Z, et al. Front Cell Dev Biol. 2024 Oct 16;12:1470875. doi: 10.3389/fcell.2024.1470875. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39479511 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources